NO973363L - Neuraminsyrederivater, deres fremstilling og medisinske anvendelse - Google Patents

Neuraminsyrederivater, deres fremstilling og medisinske anvendelse

Info

Publication number: NO973363L
Authority: NO; Norway
Prior art keywords: preparation; acid derivatives; medical use; formula; neuraminic acid
Prior art date: 1996-07-22

Application number

NO973363A

Other languages

English (en)

Other versions

NO973363D0 (no

NO317704B1 (no

Inventor

Takeshi Honda

Yoshiyuki Kobayashi

Takeshi Masuda

Makoto Yamashita

Arai Masami

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-22

Filing date

1997-07-21

Publication date

1998-01-23

1997-07-21 Application filed by Sankyo Co filed Critical Sankyo Co

1997-07-21 Publication of NO973363D0 publication Critical patent/NO973363D0/no

1998-01-23 Publication of NO973363L publication Critical patent/NO973363L/no

2004-12-06 Publication of NO317704B1 publication Critical patent/NO317704B1/no

Links

CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical class N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 title 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
102000005348 Neuraminidase Human genes 0.000 abstract 1
108010006232 Neuraminidase Proteins 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
125000001188 haloalkyl group Chemical group 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
206010022000 influenza Diseases 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
230000010076 replication Effects 0.000 abstract 1
239000002911 sialidase inhibitor Substances 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Pyrane Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO19973363A 1996-07-22 1997-07-21 Nye neuraminsyrederivater, anvendelse av disse til fremstilling av medikamenter for behandling eller forhindring av infeksjon i et pattedyt forarsaket av et sialidasebaerende virus og farmasoytiske preparater omfattende disse neuraminsyrederivatene. NO317704B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP19186296		1996-07-22
JP8688897		1997-04-04

Publications (3)

Publication Number	Publication Date
NO973363D0 NO973363D0 (no)	1997-07-21
NO973363L true NO973363L (no)	1998-01-23
NO317704B1 NO317704B1 (no)	2004-12-06

Family

ID=26427962

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19973363A NO317704B1 (no)	1996-07-22	1997-07-21	Nye neuraminsyrederivater, anvendelse av disse til fremstilling av medikamenter for behandling eller forhindring av infeksjon i et pattedyt forarsaket av et sialidasebaerende virus og farmasoytiske preparater omfattende disse neuraminsyrederivatene.

Country Status (19)

Country	Link
EP (1)	EP0823428B1 (no)
KR (1)	KR100506578B1 (no)
CN (1)	CN1127494C (no)
AT (1)	ATE211468T1 (no)
AU (1)	AU700926B2 (no)
CA (1)	CA2210492C (no)
CZ (1)	CZ291960B6 (no)
DE (1)	DE69709795T2 (no)
DK (1)	DK0823428T3 (no)
ES (1)	ES2167682T3 (no)
HU (1)	HU223494B1 (no)
ID (1)	ID17474A (no)
IL (1)	IL121305A (no)
MX (1)	MX9705559A (no)
NO (1)	NO317704B1 (no)
NZ (1)	NZ328353A (no)
PT (1)	PT823428E (no)
RU (1)	RU2124509C1 (no)
TW (1)	TW418200B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6451766B1 (en)	1996-07-22	2002-09-17	Sankyo Company, Limited	Neuraminic acid derivatives, their preparation and their medical use
US6340702B1 (en)	1996-07-22	2002-01-22	Sankyo Company, Limited	Neuraminic acid derivatives, their preparation and their medical use
US6518305B1 (en)	1998-04-23	2003-02-11	Abbott Laboratories	Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en)	1998-04-23	2002-09-24	Abbott Laboratories	Inhibitors of neuraminidases
US6593314B1 (en)	1999-10-19	2003-07-15	Abbott Laboratories	Neuraminidase inhibitors
SE9904289D0 (sv) *	1999-11-26	1999-11-26	Niklas Arnberg	Method and camposition for the treatment of adenovairal ocular infections
TWI291462B (en)	2000-04-25	2007-12-21	Daiichi Sankyo Co Ltd	Hydrate crystal of neuraminic acid compound
FR2809104B1 (fr) *	2000-05-19	2002-08-02	Univ Paris Curie	Procede de traitement de matiere vegetale, compositions comportant des derives du type n-acylglucosamine, utilisation de ces composes en tant qu'agents bio- protecteurs, et matiere vegetale traitee.
AU2001256759A1 (en) *	2000-05-19	2001-11-26	Sankyo Company Limited	Sialic acid derivatives
AUPR001000A0 (en)	2000-09-08	2000-10-05	Biota Scientific Management Pty Ltd	Novel chemical compounds and their use
WO2002076980A1 (en) *	2001-03-27	2002-10-03	Sankyo Company, Limited	Sialic acid derivatives
WO2002092555A1 (en) *	2001-05-11	2002-11-21	Sankyo Company, Limited	Sialic acid derivatives
JP5286251B2 (ja) *	2007-03-07	2013-09-11	第一三共株式会社	インフルエンザ治療剤
TWI460182B (zh) *	2007-04-11	2014-11-11	Daiichi Sankyo Co Ltd	原酸酯之製造方法
KR100930963B1 (ko) *	2008-02-26	2009-12-11	한국기계연구원	적층형 압전파이로트 밸브를 이용한 공조기용 팽창밸브
EP2476675A1 (en) *	2008-11-28	2012-07-18	Cipla Limited	Process for preparing zanamivir and intermediates for use in the process
TWI491416B (zh)	2008-12-24	2015-07-11	Daiichi Sankyo Co Ltd	吸入用乾燥粉末醫藥組成物
CA2762022A1 (en)	2009-05-15	2010-11-18	Redx Pharma Limited	Redox drug derivatives
CN102532080A (zh) *	2010-12-29	2012-07-04	中国科学院上海药物研究所	新型唾液酸衍生物及其制备方法,包含该衍生物的药物组合物,以及其用途
ES2640001T3 (es) *	2011-12-16	2017-10-31	Daiichi Sankyo Company, Limited	Procedimiento de producción de un derivado del ácido neuramínico
CN104418876B (zh) *	2013-09-09	2019-05-17	中国科学院上海有机化学研究所	扎那米韦和拉那米韦的中间体及其合成方法
CN114843564B (zh) *	2022-03-28	2023-08-25	电子科技大学	一种阴阳离子共掺杂的固体氧化物电池氧电极材料及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ288492B6 (en) *	1990-04-24	2001-06-13	Biota Scient Management	Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
CA2081068C (en) *	1991-10-23	2005-11-29	Laurence Mark Von Itzstein	Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9312531D0 (en) *	1993-06-17	1993-08-04	Glaxo Group Ltd	Process
GB9325841D0 (en) *	1993-12-17	1994-02-23	Glaxo Group Ltd	Chemical compounds
GB9400206D0 (en) *	1994-01-07	1994-03-02	Glaxo Group Ltd	Chemical compound
AUPM354694A0 (en) *	1994-01-27	1994-02-17	Biota Scientific Management Pty Ltd	Chemical compounds
GB9516276D0 (en) *	1995-08-08	1995-10-11	Biota Scient Management	Chemical compounds

1997
- 1997-07-11 AT AT97305159T patent/ATE211468T1/de active
- 1997-07-11 DK DK97305159T patent/DK0823428T3/da active
- 1997-07-11 PT PT97305159T patent/PT823428E/pt unknown
- 1997-07-11 EP EP97305159A patent/EP0823428B1/en not_active Expired - Lifetime
- 1997-07-11 DE DE69709795T patent/DE69709795T2/de not_active Expired - Lifetime
- 1997-07-11 ES ES97305159T patent/ES2167682T3/es not_active Expired - Lifetime
- 1997-07-14 IL IL12130597A patent/IL121305A/xx not_active IP Right Cessation
- 1997-07-15 CA CA002210492A patent/CA2210492C/en not_active Expired - Lifetime
- 1997-07-16 NZ NZ328353A patent/NZ328353A/en not_active IP Right Cessation
- 1997-07-16 AU AU28662/97A patent/AU700926B2/en not_active Expired
- 1997-07-21 TW TW086110312A patent/TW418200B/zh not_active IP Right Cessation
- 1997-07-21 CZ CZ19972316A patent/CZ291960B6/cs not_active IP Right Cessation
- 1997-07-21 RU RU97113367A patent/RU2124509C1/ru active
- 1997-07-21 NO NO19973363A patent/NO317704B1/no not_active IP Right Cessation
- 1997-07-21 ID IDP972509A patent/ID17474A/id unknown
- 1997-07-22 CN CN97117883A patent/CN1127494C/zh not_active Expired - Lifetime
- 1997-07-22 HU HU9701270A patent/HU223494B1/hu active IP Right Grant
- 1997-07-22 KR KR1019970034213A patent/KR100506578B1/ko not_active Expired - Lifetime
- 1997-07-22 MX MX9705559A patent/MX9705559A/es unknown

Also Published As

Publication number	Publication date
HU223494B1 (hu)	2004-08-30
HUP9701270A2 (hu)	1999-09-28
AU2866297A (en)	1998-07-02
TW418200B (en)	2001-01-11
ID17474A (id)	1998-01-08
CZ291960B6 (cs)	2003-06-18
KR980009253A (ko)	1998-04-30
PT823428E (pt)	2002-04-29
AU700926B2 (en)	1999-01-14
ATE211468T1 (de)	2002-01-15
RU2124509C1 (ru)	1999-01-10
DK0823428T3 (da)	2002-02-18
HU9701270D0 (en)	1997-09-29
CN1127494C (zh)	2003-11-12
NO973363D0 (no)	1997-07-21
NZ328353A (en)	1998-03-25
KR100506578B1 (ko)	2005-12-26
HUP9701270A3 (en)	2002-08-28
CA2210492C (en)	2002-10-29
IL121305A0 (en)	1998-01-04
IL121305A (en)	2003-01-12
DE69709795T2 (de)	2002-09-26
ES2167682T3 (es)	2002-05-16
EP0823428A2 (en)	1998-02-11
NO317704B1 (no)	2004-12-06
EP0823428A3 (en)	1998-02-25
HK1007879A1 (en)	1999-04-30
CN1172807A (zh)	1998-02-11
MX9705559A (es)	1998-05-31
EP0823428B1 (en)	2002-01-02
CZ231697A3 (cs)	1998-02-18
CA2210492A1 (en)	1998-01-22
DE69709795D1 (de)	2002-02-28

Similar Documents

Publication	Publication Date	Title
DK0823428T3 (da)	2002-02-18	Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse
US6046228A (en)	2000-04-04	Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
BR0211900A (pt)	2004-08-24	Método para inibição do desenvolvimento de vìrus e/ou virucida, análogos de nucleotìdeo de pirazina e de nucleosìdeo de pirazina, precursor do inibidor da polimerase de rna, inibidor da polimerase de rna, método para tratar pacientes infectados por vìrus, e, usos de um análogo de nucleotìdeo de pirazina ou um sal deste e de um análogo de nucleosìdeo de pirazina ou um sal deste
HUP0202593A2 (hu)	2002-12-28	Reverz transzkriptáz inhibitor hatású benzofenonok és ilyen vegyületeket tartalmazó gyógyászati készítmények
NO302574B1 (no)	1998-03-23	Indolkarbazolimider og deres anvendelse
BR9812364A (pt)	2000-09-19	Composto, uso do mesmo, composição farmacêutica, derivado de amida, e, processo para a preparação de um derivado de amida ou de um sal farmaceuticamente aceitável ou éster clivável in vivo deste
DK436081A (da)	1982-04-04	Substituerede acyl-derivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyrer og farmaceutisk acceptable salte deraf fremgangsmaade til deres fremstilling og deres anvendelse
BR0004786A (pt)	2001-05-22	Compostos farmaceuticamente ativos
KR920700217A (ko)	1992-02-19	항 바이러스성 화합물
ATE134644T1 (de)	1996-03-15	Weitere antivirale pyrimidin-nukleosiden
NO305702B1 (no)	1999-07-12	3'-substituert nukleosid-derivat eller et av dets farmas°ytisk akseptable salter, anvendelse derav og medisinsk preparat
DK0915894T3 (da)	2003-09-15	Nukleotidanaloger
DK132188A (da)	1988-09-13	Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
DK527984A (da)	1985-05-08	11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika
DK0911026T3 (da)	2003-06-30	Creatinderivater for astma
PT97407A (pt)	1992-01-31	Processo para a preparacao de (r)-9-{2-(fosfono-metoxi)-propil}-guanina
DK148288D0 (da)	1988-03-18	N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne
KR101045985B1 (ko)	2011-07-04	아릴 디케토산（ａｄｋ） 유도체를 유효성분으로 포함하는 사스 코로나 바이러스 저해용 조성물
DK0570245T3 (da)	1997-04-14	Octahydronaphthalenoximderivater til inbibering af kolesterolbiosyntese, deres fremstilling og anvendelse
NO861923L (no)	1986-11-18	Nye isoksazolderivater, fremgangsmaate til deres fremstilling, og farmasoeytiske preparater inneholdende dem.
DK0638587T3 (da)	1999-11-22	Salmyciner, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK1451184T3 (da)	2008-10-27	Dimere forbindelser og deres anvendelse som antivirale midler
SE8505534D0 (sv)	1985-11-22	Kemiska foreningar
ATE106727T1 (de)	1994-06-15	Verwendung eines benzo(b>thiophen-2- carboximidamid-derivates gegen herzinsuffizienz.
UA31078A (uk)	2000-12-15	Інгібітор вірусу імунодефіциту людини ( даримід )

Legal Events

Date	Code	Title	Description
2017-08-14	MK1K	Patent expired